The first trial of an indigenous vaccine made by Bharat Biotech was successful, with no side effects

New Delhi on Thursday, December 17, 2020

The first phase trial of the Covid 19 anti-vaccine developed by Bharat Biotech was claimed to be one hundred percent successful. The vaccine also did not cause any side effects.

The first phase of the trial was conducted on a small scale. There was no side effect. The vaccine is completely safe and accurate, according to a report by the foreign portal MRXIV. The first trial of Bharat Biotech started in September. Now the results were announced.

With the year 2020 coming to an end and now the adverse effects of corona seem to be diminishing, everyone will be relieved by the success of the corona vaccine. It was also a great reassurance that the indigenous vaccine developed by India Biotech is giving expected results. According to the Indian Council of Medical Research, the vaccine had a favorable effect on all age groups and there were indications that the immune system was boosted after the vaccination. The vaccine was developed by Bharat Biotech and was named Covexin.

Except for one person who was vaccinated, she developed corona symptoms and was admitted to the hospital on August 15. He was discharged on August 22 after a negative nuclear result. Now he is healthy and fit. Thus the first trial of Corona's indigenous vaccine was successful. Now that a decision has been made for emergency use of the vaccine, work will move on.